Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2021/11/3 申報
- 申報編號
- 0001883850-21-000007
- 申報時間
- 2021/11/3
- 交易日
- 2021/11/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $6.43 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/1 | Common Stock | S賣出處分 | −6 | $638.62F2 | −$3,831.72 | 23,185 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −11 | $639.52F3 | −$7,034.72 | 23,174 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −17 | $640.08F4 | −$10,881.36 | 23,157 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −19 | $641.52F5 | −$12,188.88 | 23,138 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −9 | $642.28F6 | −$5,780.52 | 23,129 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −1 | $643.82 | −$643.82 | 23,128 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −9 | $644.62F7 | −$5,801.58 | 23,119 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −15 | $645.41F8 | −$9,681.15 | 23,104 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −5 | $646.37F9 | −$3,231.85 | 23,099 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −8 | $647.00 | −$5,176 | 23,091 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2021 at prices ranging from $638.57 to $638.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 11 shares of Company stock on November 1, 2021 at prices ranging from $639.17 to $639.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 17 shares of Company stock on November 1, 2021 at prices ranging from $640.00 to $640.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 19 shares of Company stock on November 1, 2021 at prices ranging from $641.11 to $641.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $642.00 to $642.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $644.21 to $644.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2021 at prices ranging from $645.01 to $645.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2021 at prices ranging from $646.00 to $646.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。